13F HOLDINGS REPORT
Pennant Investors, LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0000919574-24-004628
Total Value
$382.6M
Positions
46
Other Managers
0
Confidential Omitted
No
Holdings (46)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MICRON TECHNOLOGY INC | MU | 431,000 | $56.7M | 14.82% |
| 2 | AMAZON COM INC | AMZN | 240,000 | $46.4M | 12.12% |
| 3 | TRANSDIGM GROUP INC | TDG | 32,371 | $41.4M | 10.81% |
| 4 | ECHOSTAR CORP | SATS | 2,153,209 | $38.3M | 10.02% |
| 5 | MICROSOFT CORP | MSFT | 80,000 | $35.8M | 9.35% |
| 6 | ALPHABET INC | GOOG | 183,000 | $33.3M | 8.71% |
| 7 | ANTERO RESOURCES CORP | AR | 836,000 | $27.3M | 7.13% |
| 8 | PERIMETER SOLUTIONS SA | PRM | 2,300,000 | $18.0M | 4.71% |
| 9 | ANTERO RESOURCES CORP | AR | 500,000 | $16.3M | 4.26% |
| 10 | THE ODP CORP | 88337F105 | 400,000 | $15.7M | 4.11% |
| 11 | VALMONT INDS INC | 920253101 | 40,000 | $11.0M | 2.87% |
| 12 | GE VERNOVA INC | GEV | 60,000 | $10.3M | 2.69% |
| 13 | VERTIV HOLDINGS CO | VRT | 115,000 | $10.0M | 2.60% |
| 14 | IRIS ENERGY LTD | IREN | 470,000 | $5.3M | 1.39% |
| 15 | CORE SCIENTIFIC INC NEW | 21874A106 | 500,000 | $4.7M | 1.22% |
| 16 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 170,900 | $1.6M | 0.42% |
| 17 | NURIX THERAPEUTICS INC | NRIX | 56,800 | $1.2M | 0.31% |
| 18 | NOVAVAX INC | NVAX | 60,300 | $763,398 | 0.20% |
| 19 | ALTIMMUNE INC | ALT | 109,800 | $730,170 | 0.19% |
| 20 | FIBROGEN INC | 31572Q808 | 768,400 | $685,643 | 0.18% |
| 21 | AGIOS PHARMACEUTICALS INC | AGIO | 15,100 | $651,112 | 0.17% |
| 22 | FATE THERAPEUTICS INC | FATE | 146,100 | $479,208 | 0.13% |
| 23 | TRAVERE THERAPEUTICS INC | TVTX | 55,800 | $458,676 | 0.12% |
| 24 | ENANTA PHARMACEUTICALS INC | ENTA | 35,100 | $455,247 | 0.12% |
| 25 | IGM BIOSCIENCES INC | 449585108 | 64,900 | $445,863 | 0.12% |
| 26 | ERASCA INC | ERAS | 166,200 | $392,232 | 0.10% |
| 27 | ARCUS BIOSCIENCES INC | RCUS | 23,700 | $360,951 | 0.09% |
| 28 | 89BIO INC | 282559103 | 44,500 | $356,445 | 0.09% |
| 29 | ZYMEWORKS INC | ZYME | 38,700 | $329,337 | 0.09% |
| 30 | ARCTURUS THERAPEUTICS HLDGS | ARCT | 13,100 | $318,985 | 0.08% |
| 31 | ALLOGENE THERAPEUTICS INC | ALLO | 128,400 | $299,172 | 0.08% |
| 32 | COHERUS BIOSCIENCES INC | CHRS | 168,100 | $290,813 | 0.08% |
| 33 | RELAY THERAPEUTICS INC | RLAY | 42,400 | $276,448 | 0.07% |
| 34 | REPLIMUNE GROUP INC | REPL | 30,500 | $274,500 | 0.07% |
| 35 | UNIQURE NV | QURE | 48,500 | $217,280 | 0.06% |
| 36 | SERES THERAPEUTICS INC | MCRB | 292,300 | $211,567 | 0.06% |
| 37 | COMPASS THERAPEUTICS INC | CMPX | 199,000 | $199,000 | 0.05% |
| 38 | SAGE THERAPEUTICS INC | 78667J108 | 17,500 | $190,050 | 0.05% |
| 39 | GETAROUND INC | 37427G101 | 1,348,153 | $188,741 | 0.05% |
| 40 | MACROGENICS INC | MGNX | 43,800 | $186,150 | 0.05% |
| 41 | ALLAKOS INC | 01671P100 | 186,100 | $186,100 | 0.05% |
| 42 | ALLOVIR INC | 019818103 | 215,700 | $156,016 | 0.04% |
| 43 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 32,400 | $132,516 | 0.03% |
| 44 | BIOXCEL THERAPEUTICS INC | BTAI | 83,900 | $107,392 | 0.03% |
| 45 | BLUEBIRD BIO INC | 09609G100 | 87,400 | $86,019 | 0.02% |
| 46 | GRAB HOLDINGS LIMITED | GRABW | 80,000 | $12,888 | 0.00% |